Polymorphisms in the IL-12B gene and outcome of HCV infection

Journal of Interferon and Cytokine Research

Volumn 25, Issue 5, 2005, Pages 271-276

  Houldsworth, Annwyne ^a   Metzner, Magdalena ^a,b   Rossol, Siegbert ^c   Shaw, Steve ^d   Kaminski, Edward ^a,b   Demaine, Andy G ^a   Cramp, Matthew E ^a,b  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

^c Department of Medicine ^*  (Germany)

^d UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; INTERLEUKIN 12; VIRUS RNA;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HOMOZYGOSITY; HUMAN; IL-12B GENE; INTRON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA ISOLATION; SINGLE NUCLEOTIDE POLYMORPHISM; UNTRANSLATED REGION;

3' UNTRANSLATED REGIONS; ADULT; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA; FEMALE; HAPLOTYPES; HEPATITIS C; HEPATITIS C, CHRONIC; HOMOZYGOTE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTRONS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROMOTER REGIONS (GENETICS); PROTEIN SUBUNITS; SEQUENCE DELETION;

HEPATITIS C VIRUS;

EID: 18644384434     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2005.25.271     Document Type: Article

References (31)

1. ALTER, M.J. (1999). Hepatitis C virus infection in the United States. J. Hepatol. 31, 88-91.
2. DIEPOLDER, H.M., ZACHOVAL, R., HOFFMANN, R.M., WIERENGA, E.A., SANTANTONIO, T., JUNG, M.C., EICHENLAUB, D., and PAPE, G.R. (1995). Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346, 1006-1007.
3. (+) T-cell response in acute hepatitis C. Gastroenterology 117, 933-941.
4. CRAMP, M.E., CARUCCI, P., ROSSOL, S., CHOKSHI, S., MAERTENS, G., WILLIAMS, R., and NAOUMOV, N.V (1999). Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia. Gut 44, 424-429.
5. TAKAKI, A., WIESE, M., MAERTENS, G., DEPLA, E., SEIFERT, U., LIEBETRAU, A., MILLER, J.L., MANNS, M.P., and REHERMANN, B. (2000). Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat. Med. 6, 578-582.
6. CRAMP, ME., ROSSOL, S., CHOKSHI, S., CARUCCI, P., WILLIAMS, R., and NAOUMOV, N.V. (2000). Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C. Gastroenterology 118, 346-355.
7. CRAMP, M.E., CARUCCI, P., UNDERHILL, J., NAOUMOV, N.V., WILLIAMS, R., and DONALDSON, P.T. (1998). Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J. Hepatol. 29, 207-213.
8. THURSZ, M. (2001). MHC and the viral hepatitides. Q. J. Med. 94, 287-291.
9. EDWARDS-SMITH, C.J., JONSSON, J.R., PURDIE, D.M., BANSAL, A., SHORTHOUSE, C., and POWELL, E.E. (1999). Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alpha. Hepatology 30, 526-530.
10. CHAN, S.H., PERUSSIA, B., GUPTA, J.W., KOBAYASHI, M., POSPISIL, M., YOUNG, H.A., WOLF, S.F, YOUNG, D., CLARK, S.C., and TRINCHIERI, G. (1991). Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173, 869-879.
11. WOLF, S.F., TEMPLE, P.A., KOBAYASHI, M., YOUNG, D., DICIG, M., LOWE, L., DZIALO, R., FITZ, L., FERENZ, C., HEWICK, R.M., et al. (1991). Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146, 3074-3081.
12. MANETTI, R., PARRONCHI, P., GIUDIZI, M.G., PICCINNI, M.P., MAGGI, E., TRINCHIERI, G., and ROMAGNANI, S. (1993). Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204.
13. TRINCHIERI, G. (1995). Interleukin-12 a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
14. YAP, G., PESIN, M., and SHER, A. (2000). Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165, 628-631.
15. GATELY, M.K., RENZETTI, L.M., MAGRAM, J., STERN, A.S., ADORINI, L., GUBLER, U., and PRESKY, D.H. (1998). The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16, 495-521.
16. HUANG, D., CANCILLA, M.R., and MORAHAN, G. (2000). Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun. 1, 515-520.
17. MORAHAN, G., HUANG, D., WU, M., HOLT, B.J., WHITE, G.P., KENDALL, G.E., SLY, P.D., and HOLT, P.G. (2002). Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children. Lancet 360, 455-459.
18. MORAHAN, G., HUANG, D., YMER, S.I., CANCILLA, M.R., STEPHEN, K., DABADGHAO, P., WERTHER, G., TAIT, B.D., HARRISON, L.C., and COLMAN, P.G. (2001). Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat. Genet. 27, 218-221.
19. TSUNEMI, Y., SAEKI, H., NAKAMURA, K., SEKIYA, T., HIRAI, K., FUJITA, H., ASANO, N., KISHIMOTO, M., TANIDA, Y., KAKINUMA, T., MITSUI, H., TADA, Y., WAKUGAWA, M., TORII, H., KOMINE, M., ASAHINA, A., and TAMAKI, K. (2002.) Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J. Dermatol. Sci. 30, 161-166.
20. WANG, C., TANG, J., SONG, W., LOBASHEVSKY, E., WILSON, C.M., and KASLOW, R.A. (2004). HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 39, 978-988.
21. LE CAM, A., and LEGRAVEREND, C. (1995). Transcriptional repression, a novel function for 3′ untranslated regions. Eur. J. Biochem. 231, 620-627.
22. HILL, A.V. (1998). The immunogenetics of human infectious diseases. Annu. Rev. Immunol. 16, 593-617.
23. PIAZZOLLA, G., TORTORELLA, C., FIORE, G., FANELLI, M., PISCONTI, A., and ANTONACI, S. (2001). Interleukin-12 p40/p70 ratio and in vivo responsiveness to IFN-α treatment in chronic hepatitis C. J. Interferon Cytokine Res. 21, 453-461.
24. WOLDAY, D., BERHE, N., BRITTON, S., and AKUFFO, H. (2000). HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani. AIDS 14, 921-929.
25. SCHLAAK, J.F., PITZ, T., LOHR, H.F., MEYER, Z.U.M., BUSCHENFELDE, K.H., and GERKEN, G. (1998). Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells. J. Med. Virol. 56, 112-117.
26. YIN, M.-L., ZHU, W.-F., WEI, L., XU, X.Y., SUN, D.G., WANG, Y.B., FAN, W.M., YU, M., TIAN, X.L., WANG, Q.X., GAO, Y., and ZHUANG, H. (2004) Association of interleukin-12 p40 gene 3′-untranslated region polymorphism and outcome of HCV infection. World J. Gastroenterol. 10, 2330-2333.
27. MUELLER, T., MAS-MARQUES, A., SARRAZIN, C., WIESE, M., HALANGK, J., WITT, H., AHLENSTIEL, G., SPENGLER, U., GOEBEL, U., WIEDENMANN, B., SCHREIER, E., and BERG, T. (2004). Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection. J. Hepatol. 41, 652-658.
28. SEEGERS, D., ZWIERS, A., STROBER, W., PENA, A.S., and BOUMA, G. (2002). A TaqI polymorphism in the 3′UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun. 3, 419-423.
29. GRZYBOWSKA, E.A., WILCZYNSKA, A., and SIEDLECKI, J.A. (2001). Regulatory functions of 3′UTRs. Biochem. Biophys. Res. Commun. 288, 291-295.
30. LU, J.Y., and SCHNEIDER, R.J. (2004.) Tissue distribution of AU-rich mRNA-binding proteins involved in regulation of mRNA decay. J. Biol. Chem. 279, 12974-12979.
31. PESOLE, G., LIUNI, S., GRILLO, G., LICCIULLI, F., MIGNONE, F., GISSI, C., and SACCONE, C. (2002). UTRdb and UTRsite: specialized databases of sequences and functional elements of 5′ and 3′ untranslated regions of eukaryotic mRNAs. Update 2002. Nucleic Acids Res. 30, 335-340.